111
Participants
Start Date
November 1, 2022
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Docetaxel
60 mg/m2 i.v. day 1
Cisplatin
60 mg/m2 i.v. day 1-3
Capecitabine
750 mg/m2 po bid day 1-14
Concomitant chemoradiotherapy
"Radiotherapy: using intensity-modulated radiation therapy (IMRT)~Gross tumor volume (GTV) for primary tumor: 66-70 Gy in total, 2.0\~2.2 Gy per day, 5 days per week~Clinical target volume (CTV) for lesions closely related to the primary lesion and metastatic lymph nodes: 65\~70 Gy in total, 1.7\~2.0 Gy per day, 5 days per week~Prophylactic irradiation for sites of suspected subclinical spread: 50\~60 Gy in total, 1.7\~2.0 Gy per day, 5 days per week~Concurrent chemotherapy: cisplatin 80 mg/m2 on days 1-3 every 3 weeks."
Surgery
Neck dissection and primary tumor resection
NOT_YET_RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Eye & ENT Hospital, Fudan University, Shanghai
NOT_YET_RECRUITING
Shandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong University, Jinan
Shandong Provincial Hospital
OTHER_GOV
Harbin Medical University Third Affiliated Hospital
OTHER
Eye & ENT Hospital of Fudan University
OTHER